Healthy and Patient Type 2 Innate Lymphoid Cells are Differently Affected by in vitro Culture Conditions

References

• Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454(7203):445–454. doi:10.1038/nature07204
   PubMed Web of Science ®Google Scholar
• Eberl G, Colonna M, Di Santo JP, et al. Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology. Science. 2015;348(6237):aaa6566. doi:10.1126/science.aaa6566
   PubMed Web of Science ®Google Scholar
• Licona-Limon P, Kim LK, Palm NW, et al. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol. 2013;14(6):536–542. doi:10.1038/ni.2617
   PubMed Web of Science ®Google Scholar
• McKenzie AN. Type-2 innate lymphoid cells in asthma and allergy. Ann Am Thorac Soc. 2014;11(Suppl 5):S263–70. doi:10.1513/AnnalsATS.201403-097AW
   PubMedGoogle Scholar
• Pasha MA, Patel G, Hopp R, et al. Role of innate lymphoid cells in allergic diseases. Allergy Asthma Proc. 2019;40(3):138–145. doi:10.2500/aap.2019.40.4217
   Web of Science ®Google Scholar
• Doherty TA, Broide DH. Airway innate lymphoid cells in the induction and regulation of allergy. Allergol Int. 2019;68(1):9–16. doi:10.1016/j.alit.2018.11.001
   PubMed Web of Science ®Google Scholar
• Vivier E, Artis D, Colonna M, et al. Innate lymphoid cells: 10 years on. Cell. 2018;174(5):1054–1066. doi:10.1016/j.cell.2018.07.017
   PubMed Web of Science ®Google Scholar
• Wojno ED, Monticelli LA, Tran SV, et al. The prostaglandin D(2) receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung. Mucosal Immunol. 2015;8(6):1313–1323. doi:10.1038/mi.2015.21
   PubMed Web of Science ®Google Scholar
• Mjosberg JM, Trifari S, Crellin NK, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011;12(11):1055–1062. doi:10.1038/ni.2104
   PubMed Web of Science ®Google Scholar
• Hochdorfer T, Winkler C, Pardali K, et al. Expression of c-Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cells. Eur J Immunol. 2019;49(6):884–893. doi:10.1002/eji.201848006
   PubMed Web of Science ®Google Scholar
• Bernink JH, Ohne Y, Teunissen MBM, et al. c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies. Nat Immunol. 2019;20(8):992–1003. doi:10.1038/s41590-019-0423-0
   PubMed Web of Science ®Google Scholar
• Brestoff JR, Kim BS, Saenz SA, et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature. 2015;519(7542):242–246. doi:10.1038/nature14115
   PubMed Web of Science ®Google Scholar
• Trabanelli S, Chevalier MF, Martinez-Usatorre A, et al. Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis. Nat Commun. 2017;8(1):593. doi:10.1038/s41467-017-00678-2
   PubMed Web of Science ®Google Scholar
• Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464(7293):1367–1370. doi:10.1038/nature08900
   PubMed Web of Science ®Google Scholar
• Maric J, Ravindran A, Mazzurana L, et al. Cytokine-induced endogenous production of prostaglandin D2 is essential for human group 2 innate lymphoid cell activation. J Allergy Clin Immunol. 2019;143(6):2202–2214 e5. doi:10.1016/j.jaci.2018.10.069
   Web of Science ®Google Scholar
• Klose CS, Artis D. Neuronal regulation of innate lymphoid cells. Curr Opin Immunol. 2019;56:94–99. doi:10.1016/j.coi.2018.11.002
   Web of Science ®Google Scholar
• Wallrapp A, Riesenfeld SJ, Burkett PR, et al. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature. 2017;549(7672):351–356. doi:10.1038/nature24029
   PubMed Web of Science ®Google Scholar
• Sui P, Wiesner DL, Xu J, et al. Pulmonary neuroendocrine cells amplify allergic asthma responses. Science. 2018;360(6393):6393. doi:10.1126/science.aan8546
   Web of Science ®Google Scholar
• Cardoso V, Chesné J, Ribeiro H, et al. Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature. 2017;549(7671):277–281. doi:10.1038/nature23469
   PubMed Web of Science ®Google Scholar
• Klose CSN, Mahlakõiv T, Moeller JB, et al. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Nature. 2017;549(7671):282–286. doi:10.1038/nature23676
   PubMed Web of Science ®Google Scholar
• Nussbaum JC, Van Dyken SJ, von Moltke J, et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature. 2013;502(7470):245–248. doi:10.1038/nature12526
   PubMed Web of Science ®Google Scholar
• Nagashima H, Mahlakõiv T, Shih H-Y, et al. Neuropeptide CGRP limits group 2 innate lymphoid cell responses and constrains type 2 inflammation. Immunity. 2019;51(4):682–695. doi:10.1016/j.immuni.2019.06.009
   Web of Science ®Google Scholar
• Wallrapp A, Burkett PR, Riesenfeld SJ, et al. Calcitonin gene-related peptide negatively regulates alarmin-driven type 2 innate lymphoid cell responses. Immunity. 2019;51(4):709–723 e6. doi:10.1016/j.immuni.2019.09.005
   Web of Science ®Google Scholar
• Xu H, Ding J, Porter CBM, et al. Transcriptional atlas of intestinal immune cells reveals that neuropeptide alpha-CGRP modulates group 2 innate lymphoid cell responses. Immunity. 2019;51(4):696–708 e9. doi:10.1016/j.immuni.2019.09.004
   Web of Science ®Google Scholar
• Serafini N, Vosshenrich CA, Di Santo JP. Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol. 2015;15(7):415–428. doi:10.1038/nri3855
   PubMed Web of Science ®Google Scholar
• Sciume G, Fionda C, Stabile H, et al. Negative regulation of innate lymphoid cell responses in inflammation and cancer. Immunol Lett. 2019;215(p):28–34. doi:10.1016/j.imlet.2019.01.011
   Web of Science ®Google Scholar
• Kabata H, Moro K, Koyasu S. The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms. Immunol Rev. 2018;286(1):37–52. doi:10.1111/imr.12706
   PubMed Web of Science ®Google Scholar
• Ducimetiere L, Vermeer M, Tugues S. The interplay between innate lymphoid cells and the tumor microenvironment. Front Immunol. 2019;10(p):2895. doi:10.3389/fimmu.2019.02895
   Web of Science ®Google Scholar
• Trabanelli S, Gomez-Cadena A, Salomé B, et al. Human innate lymphoid cells (ILCs): toward a uniform immune-phenotyping. Cytometry B Clin Cytom. 2018;94(3):392–399. doi:10.1002/cyto.b.21614
   Web of Science ®Google Scholar
• Spits H, Artis D, Colonna M, et al. Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145–149. doi:10.1038/nri3365
   PubMed Web of Science ®Google Scholar
• Camelo A, Rosignoli G, Ohne Y, et al. IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells. Blood Adv. 2017;1(10):577–589. doi:10.1182/bloodadvances.2016002352
   PubMed Web of Science ®Google Scholar
• Lim AI, Li Y, Lopez-Lastra S, et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell. 2017;168(6):086–1100 e10. doi:10.1016/j.cell.2017.02.021
   Web of Science ®Google Scholar
• Simoni Y, Fehlings M, Kløverpris HN, et al. Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity. 2017;46(1):148–161. doi:10.1016/j.immuni.2016.11.005
   PubMed Web of Science ®Google Scholar
• Maric J, Ravindran A, Mazzurana L, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141(5):1761–1773. doi:10.1016/j.jaci.2017.09.050
   PubMed Web of Science ®Google Scholar
• Nagasawa M, Heesters BA, Kradolfer CMA, et al. KLRG1 and NKp46 discriminate subpopulations of human CD117(+)CRTH2(-) ILCs biased toward ILC2 or ILC3. J Exp Med. 2019;216(8):1762–1776. doi:10.1084/jem.20190490
   Web of Science ®Google Scholar
• Taylor S, Huang Y, Mallett G, et al. PD-1 regulates KLRG1(+) group 2 innate lymphoid cells. J Exp Med. 2017;214(6):1663–1678. doi:10.1084/jem.20161653
   PubMed Web of Science ®Google Scholar
• Chiossone L, Vivier E. Immune checkpoints on innate lymphoid cells. J Exp Med. 2017;214(6):1561–1563. doi:10.1084/jem.20170763
   Web of Science ®Google Scholar
• Shiow LR, Rosen DB, Brdičková N, et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature. 2006;440(7083):540–544. doi:10.1038/nature04606
   PubMed Web of Science ®Google Scholar
• Munneke JM, Björklund AT, Mjösberg JM, et al. Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease. Blood. 2014;124(5):812–821. doi:10.1182/blood-2013-11-536888
   PubMed Web of Science ®Google Scholar
• Oliphant CJ, Hwang Y, Walker J, et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity. 2014;41(2):283–295. doi:10.1016/j.immuni.2014.06.016
   PubMed Web of Science ®Google Scholar
• Rao A, Strauss O, Kokkinou E, et al. Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs. Nat Commun. 2020;11(1):2049. doi:10.1038/s41467-020-15695-x
   PubMed Web of Science ®Google Scholar
• He Y, Cao J, Zhao C, et al. TIM-3, a promising target for cancer immunotherapy. Onco Targets Ther. 2018;11:7005–7009. doi:10.2147/OTT.S170385
   PubMed Web of Science ®Google Scholar
• Chu DT, Bac ND, Nguyen K-H, et al. An update on anti-CD137 antibodies in immunotherapies for cancer. Int J Mol Sci. 2019;20(8):1822. doi:10.3390/ijms20081822
   Web of Science ®Google Scholar
• Moro K, Yamada T, Tanabe M, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2010;463(7280):540–544. doi:10.1038/nature08636
   PubMed Web of Science ®Google Scholar
• Wilhelm C, Hirota K, Stieglitz B, et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol. 2011;12(11):1071–1077. doi:10.1038/ni.2133
   PubMed Web of Science ®Google Scholar
• Turner JE, Morrison PJ, Wilhelm C, et al. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med. 2013;210(13):2951–2965. doi:10.1084/jem.20130071
   PubMed Web of Science ®Google Scholar
• Krabbendam L, Bal SM, Spits H, et al. New insights into the function, development, and plasticity of type 2 innate lymphoid cells. Immunol Rev. 2018;286(1):74–85. doi:10.1111/imr.12708
   Web of Science ®Google Scholar
• Colonna M. Innate lymphoid cells: diversity, plasticity, and unique functions in immunity. Immunity. 2018;48(6):1104–1117. doi:10.1016/j.immuni.2018.05.013
   PubMed Web of Science ®Google Scholar
• Lim AI, Menegatti S, Bustamante J, et al. IL-12 drives functional plasticity of human group 2 innate lymphoid cells. J Exp Med. 2016;213(4):569–583. doi:10.1084/jem.20151750
   PubMed Web of Science ®Google Scholar
• Golebski K, Ros XR, Nagasawa M, et al. IL-1beta, IL-23, and TGF-beta drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation. Nat Commun. 2019;10(1):2162. doi:10.1038/s41467-019-09883-7
   PubMed Web of Science ®Google Scholar
• Bartemes KR, Kephart GM, Fox SJ, et al. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol. 2014;134(3):671–678 e4. doi:10.1016/j.jaci.2014.06.024
   PubMed Web of Science ®Google Scholar
• Winkler C, Hochdörfer T, Israelsson E, et al. Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients. J Allergy Clin Immunol. 2019;144(1):61–69 e7. doi:10.1016/j.jaci.2019.01.027
   Web of Science ®Google Scholar
• Lao-Araya M, Steveling E, Scadding GW, et al. Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy. J Allergy Clin Immunol. 2014;134(5):1193–5 e4. doi:10.1016/j.jaci.2014.07.029
   PubMed Web of Science ®Google Scholar
• Robinette ML, Fuchs A, Cortez VS, et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat Immunol. 2015;16(3):306–317. doi:10.1038/ni.3094
   PubMed Web of Science ®Google Scholar
• Wilhelm C, Harrison OJ, Schmitt V, et al. Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection. J Exp Med. 2016;213(8):1409–1418. doi:10.1084/jem.20151448
   PubMed Web of Science ®Google Scholar
• Monticelli LA, Buck MD, Flamar A-L, et al. Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat Immunol. 2016;17(6):656–665. doi:10.1038/ni.3421
   PubMed Web of Science ®Google Scholar
• Klose CSN, Artis D. Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity. Cell Res. 2020;30(6):475–491. doi:10.1038/s41422-020-0323-8
   PubMed Web of Science ®Google Scholar
• Boonpiyathad T, Tantilipikorn P, Ruxrungtham K, et al. IL-10-producing innate lymphoid cells increased in house-dust-mite allergic rhinitis patients following immunotherapy. J Allergy Clin Immunol. 2020.
   Web of Science ®Google Scholar
• Trakarnsanga K, Wilson MC, Heesom KJ, et al. Secretory factors from OP9 stromal cells delay differentiation and increase the expansion potential of adult erythroid cells in vitro. Sci Rep. 2018;8(1):1983. doi:10.1038/s41598-018-20491-1
   Web of Science ®Google Scholar